Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Holdings Decreas

Picton Mahoney Asset Management reduced its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 12.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,727 shares of the company’s stock after selling 6,048 shares during the quarter. […]

Related Keywords

Montreal , Quebec , Canada , Cedric Francois , Alec Machiels , Raymond James Financial Services Advisors Inc , Apellis Pharmaceuticals Profile , Apellis Pharmaceuticals , Oppenheimer Co , Wells Fargo Company , Needham Company , Jpmorgan Chase Co , Nasdaq , Citigroup , Quarter For Apellis Pharmaceuticals , News Ratings For Apellis Pharmaceuticals Daily , Apellis Pharmaceuticals Inc , Securities Exchange Commission , Apellis Pharmaceuticals Price Performance , National Bank , Picton Mahoney Asset Management , Free Report , Mahoney Asset Management , Montreal Can , Raymond James Financial Services Advisors , James Financial Services Advisors , Get Free Report , Director Alec Machiels , Visit Holdingschannel , Apellis Pharmaceuticals Daily , Nasdaq Apls , Apls , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,